Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Clinical series of patients with cutaneous melanoma followed-up at the Novara Melanoma Centre from 1983 to 2009: description of the cohort and prognostic factors.

Miglino B, Pertusi G, Giorgione R, Tiberio R, Astolfi S, Leigheb F, Colombo E.

G Ital Dermatol Venereol. 2013 Oct;148(5):443-51.

PMID:
24005136
2.

Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.

Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF.

J Am Acad Dermatol. 2001 May;44(5):762-6.

PMID:
11312421
3.

Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.

Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC 2nd, McMasters KM.

Am J Surg. 2011 Dec;202(6):659-64; discussion 664-5. doi: 10.1016/j.amjsurg.2011.06.048.

PMID:
22137134
4.

[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].

de Vries M, Jager PL, Suurmeijer AJ, Plukker JT, van Ginkel RJ, Hoekstra HJ.

Ned Tijdschr Geneeskd. 2005 Aug 13;149(33):1845-51. Dutch.

PMID:
16128183
5.

Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.

Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC 2nd, McMasters KM, Scoggins CR, Callender GG.

Am Surg. 2011 Aug;77(8):1009-13.

PMID:
21944515
6.

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, van Diest PJ, Pijpers R, Ferwerda CC, Vuylsteke RJ, Meijer S.

Cancer. 2001 Jun 15;91(12):2401-8.

PMID:
11413531
7.

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.

Ann Surg. 2012 Jan;255(1):128-33. doi: 10.1097/SLA.0b013e3182306c72.

PMID:
21975320
8.

Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?

Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR.

Cancer. 2010 Mar 15;116(6):1535-44. doi: 10.1002/cncr.24895.

9.

Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.

Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M, Miller JR 3rd, Leong SP.

Arch Dermatol. 1998 Aug;134(8):983-7.

PMID:
9722728
10.

Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?

Nahabedian MY, Tufaro AP, Manson PN.

Ann Plast Surg. 2003 Jun;50(6):601-6.

PMID:
12783009
11.

Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.

Kunte C, Geimer T, Baumert J, Konz B, Volkenandt M, Flaig M, Ruzicka T, Berking C, Schmid-Wendtner MH.

Melanoma Res. 2010 Aug;20(4):330-7. doi: 10.1097/CMR.0b013e32833ba9ff.

PMID:
20526218
12.

Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.

Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L.

Br J Dermatol. 2007 Jul;157(1):58-67. Epub 2007 May 14.

PMID:
17501957
13.

Prognostic factors in young women with cutaneous melanoma.

Burton AL, Egger ME, Quillo AR, Stromberg AJ, Hagendoorn L, Scoggins CR, Martin RC 2nd, McMasters KM, Callender GG.

Am J Surg. 2014 Jan;207(1):102-8. doi: 10.1016/j.amjsurg.2013.10.002. Epub 2013 Oct 25.

PMID:
24330977
14.

The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.

Zdzienicki M, Rutkowski P, Nowecki ZI, van Akkooi AC, Michej W, Dziewirski W, Świtaj T, Pieńkowski A, Sałamacha M, Bylina E, Eggermont AM.

Eur J Surg Oncol. 2013 Mar;39(3):304-10. doi: 10.1016/j.ejso.2012.12.014. Epub 2013 Jan 5.

PMID:
23298828
15.

Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.

Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E.

Br J Cancer. 2005 Feb 28;92(4):662-7.

16.

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.

Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.

PMID:
18427039
17.

The effect of delay time between primary melanoma biopsy and sentinel lymph node dissection on sentinel node status, recurrence, and survival.

Parrett BM, Accortt NA, Li R, Dosanjh AS, Thummala S, Kullar R, Cleaver JE, Kashani-Sabet M, Leong SP.

Melanoma Res. 2012 Oct;22(5):386-91. doi: 10.1097/CMR.0b013e32835861f6.

PMID:
22955010
18.

Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.

Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E.

Ann Surg Oncol. 2007 Dec;14(12):3566-74. Epub 2007 Oct 9.

PMID:
17924169
19.

Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.

Egger ME, Huber KM, Dunki-Jacobs EM, Quillo AR, Scoggins CR, Martin RC 2nd, Stromberg AJ, McMasters KM, Callender GG.

J Am Coll Surg. 2013 Jul;217(1):37-44; discussion 44-5. doi: 10.1016/j.jamcollsurg.2013.05.006.

PMID:
23791271
20.

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.

Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.

Eur J Cancer. 2009 Sep;45(14):2537-45. doi: 10.1016/j.ejca.2009.05.034. Epub 2009 Jun 22.

PMID:
19553103

Supplemental Content

Support Center